Literature DB >> 12167160

MCM3-binding GANP DNA-primase is associated with a novel phosphatase component G5PR.

Yoshihiko Kono1, Kazuhiko Maeda, Kazuhiko Kuwahara, Hideyuki Yamamoto, Eishichi Miyamoto, Kazuyoshi Yonezawa, Katsumasa Takagi, Nobuo Sakaguchi.   

Abstract

BACKGROUND: GANP, carrying DNA-primase and MCM3-binding domains, is up-regulated in germinal centre B cells. To understand the regulatory function of GANP upon MCM complex, we searched for GANP-associated molecules by yeast two-hybrid screening.
RESULTS: Using the 1 kb fragment (G5) of the ganp cDNA, we identified a clone named G5PR that is structurally homologous to known regulatory subunits of protein phosphatases (PPases) and determined the association of G5PR with GANP in vivo in the DNA transfectant. G5PR is associated with protein phosphatase 5 (PP5) through its tetratricopeptide-repeat (TPR) domain. Pull-down assays demonstrated that G5PR is also associated with protein phosphatase 2A (PP2A), the complex of A subunit (PR65) and the catalytic (C) subunit (PP2Ac), similar to the B" subunit. The G5PR-associated complex had phosphatase activity on casein, histone H1 and MCM3 in vitro, but the addition of G5PR did not stimulate or inhibit the phosphatase activities of PP5 and PP2A. The cellular localization of G5PR in transfected cells varies during cell cycling, appearing in the nucleus during prophase, in the peri-chromatin during mitotic phase, and in the cytoplasm after cell division.
CONCLUSION: G5PR is capable of recruiting two kinds of PPases, PP5 and PP2A, into the GANP/MCM3 complex, which might regulate its phosphorylation state during cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12167160     DOI: 10.1046/j.1365-2443.2002.00562.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  8 in total

1.  Calcium-binding proteins that are type B″ regulatory subunits of phosphatase 2A in Giardia intestinalis.

Authors:  Magda E Alvarado; Claudia Rubiano; William Sánchez; Andrea Díaz; Moisés Wasserman
Journal:  Parasitol Res       Date:  2018-07-24       Impact factor: 2.289

Review 2.  PP2A holoenzymes negatively and positively regulate cell cycle progression by dephosphorylating pocket proteins and multiple CDK substrates.

Authors:  Alison Kurimchak; Xavier Graña
Journal:  Gene       Date:  2012-02-22       Impact factor: 3.688

3.  Protein phosphatases and chromatin modifying complexes in the inflammatory cascade in acute pancreatitis.

Authors:  Javier Escobar; Javier Pereda; Alessandro Arduini; Juan Sandoval; Luis Sabater; Luis Aparisi; Gerardo López-Rodas; Juan Sastre
Journal:  World J Gastrointest Pharmacol Ther       Date:  2010-06-06

4.  Regulation of apoptosis signal-regulating kinase 1 (ASK1) by polyamine levels via protein phosphatase 5.

Authors:  Mikhail A Kutuzov; Alexandra V Andreeva; Tatyana A Voyno-Yasenetskaya
Journal:  J Biol Chem       Date:  2005-05-12       Impact factor: 5.157

5.  Diversity in genomic organisation, developmental regulation and distribution of the murine PR72/B" subunits of protein phosphatase 2A.

Authors:  Karen Zwaenepoel; Justin V Louis; Jozef Goris; Veerle Janssens
Journal:  BMC Genomics       Date:  2008-08-20       Impact factor: 3.969

6.  Protein phosphatase subunit G5PR is needed for inhibition of B cell receptor-induced apoptosis.

Authors:  Yan Xing; Hideya Igarashi; Xiaodan Wang; Nobuo Sakaguchi
Journal:  J Exp Med       Date:  2005-08-29       Impact factor: 14.307

7.  The mir-465 family is upregulated with age and attenuates growth hormone signaling in mouse liver.

Authors:  Amy E Elias; Bianca Kun; Ian M C Sabula; Gail Golomb-Mello; Andrea Cespedes Zablah; Jill A Kreiling
Journal:  Aging Cell       Date:  2019-01-13       Impact factor: 9.304

8.  The cellular protein MCM3AP is required for inhibition of cellular DNA synthesis by the IE86 protein of human cytomegalovirus.

Authors:  Emma Poole; Mark Bain; Linda Teague; Yoshinori Takei; Ron Laskey; John Sinclair
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.